Clincosm LogoSign in Get a demo

Discarded Materials Study

Sponsor
Reproductive Medicine Associates of New Jersey (Other)
Overall Status
Recruiting
CT.gov ID
NCT01219335
Collaborator
(none)
10,000
Enrollment
1
Location
284
Duration (Months)
35.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Use of discarded embryos to advance laboratory expertise and technology in the area of human embryo development and assisted reproductive technologies

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    1- Testing methods or freezing before implementing techniques. 2- Develop cell surgery and micromanipulation techniques. 3- Develop methods to optimize the determinations of genes and chromosomes 4- Quality-assess laboratory equipment. 5- Test proficiency of laboratory staff. 6- Analyze what effects the early development of embryos. 7- Develop new methods and media to allow for higher survival rates of embryos. 8- Develop non-invasive tests for predicting embryo quality to predict IVF success.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Laboratory Evaluation of De-identified, Developmentally Arrested Embryos of Embryos Diagnosed as Having an Abnormal Number of Chromosomes for Optimization of Techniques for Assisted Reproduction
    Study Start Date :
    Apr 1, 2003
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Methods for freezing -embryos [duration of the study]

      To test, standardize and implement better methods for the freezing embryos prior to these techniques being used in the clinical setting

    Secondary Outcome Measures

    1. Development non-invasive tests [duration of the study]

      To develop non-invasive tests for predicting embryo quality as well as IVF success

    2. Factors that control embryo development [duration of the study]

      To analyze embryos to learn more about what controls their early development and function.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    none

    Exclusion Criteria:

    none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Reproductive Medicine Associates of new Jersey Basking Ridge New Jersey United States 07920

    Sponsors and Collaborators

    • Reproductive Medicine Associates of New Jersey

    Investigators

    • Principal Investigator: Richard T Scott, MD, Reproductive Medicine Associates of New Jersey

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Reproductive Medicine Associates of New Jersey
    ClinicalTrials.gov Identifier:
    NCT01219335
    Other Study ID Numbers:
    • RMA-00-02
    First Posted:
    Oct 13, 2010
    Last Update Posted:
    Jan 14, 2022
    Last Verified:
    Jan 1, 2022
    Keywords provided by Reproductive Medicine Associates of New Jersey
    IVF
    Additional relevant MeSH terms:
    Infertility

    Study Results

    No Results Posted as of Jan 14, 2022